ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass

Chemotherapy promotes the development of cachexia, a debilitating condition characterized by muscle and fat loss. ACVR2B/Fc, an inhibitor of the Activin Receptor 2B signaling, has been shown to preserve muscle mass and prolong survival in tumor hosts, and to increase bone mass in models of osteogene...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Barreto, Rafael, Kitase, Yukiko, Matsumoto, Tsutomu, Pin, Fabrizio, Colston, Kyra C., Couch, Katherine E., O’Connell, Thomas M., Couch, Marion E., Bonewald, Lynda F., Bonetto, Andrea
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5665981/
https://ncbi.nlm.nih.gov/pubmed/29089584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-15040-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares